Q4 2024 · 13F-HR
Octagon Capital Advisors LPholdings as filed
Filed 2025-02-14 · accession 0001839435-25-000002
$607.7M
Reported value
33
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $96.0M | 15.8% | 3,006,980 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $54.9M | 9.03% | 2,059,387 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $46.0M | 7.57% | 2,110,167 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $33.4M | 5.49% | 1,993,052 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $26.5M | 4.37% | 571,264 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $24.5M | 4.03% | 9,202,907 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $22.9M | 3.77% | 332,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $21.6M | 3.55% | 2,763,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $21.1M | 3.47% | 488,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $21.0M | 3.46% | 3,018,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $20.7M | 3.41% | 2,425,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $18.1M | 2.97% | 10,450,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $17.3M | 2.84% | 250,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $16.7M | 2.74% | 870,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $16.6M | 2.73% | 18,350,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $15.7M | 2.59% | 668,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $14.9M | 2.45% | 778,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $13.2M | 2.17% | 1,115,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $13.0M | 2.13% | 308,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $12.9M | 2.12% | 5,136,795 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $12.1M | 1.99% | 441,600 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $12.0M | 1.97% | 904,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $11.6M | 1.91% | 1,370,000 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $7.9M | 1.31% | 10,000,000 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $7.7M | 1.26% | 4,848,802 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $7.4M | 1.21% | 2,304,752 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $6.9M | 1.14% | 303,000 | Common | SOLE |
| 019818202 | — | ALLOVIR INC | $4.7M | 0.78% | 11,215,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $3.3M | 0.54% | 900,000 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.43% | 250,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.5M | 0.42% | 152,000 | PUT | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $1.4M | 0.23% | 992,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $830,814 | 0.14% | 312,336 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.